In addition, no significant effect in the expression of CCL2 was observed after the treatment of adipocytes with CFS with the exception of CFS from the TMC3108 strain that up-regulated this chemokine. This evidence concerns the gene CCL2 and myalgic encephalomeyelitis/chronic fatigue syndrome.